Pharmaceuticals in the United States

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the United States pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The US pharmaceuticals market had total revenues of $401.0bn in 2017, representing a compound annual growth rate (CAGR) of 8% between 2013 and 2017.

- High consumption and prices in the United States continues to propel growth in the market.

- The US has more patents, R&D development facilities, industry employment and major global companies than any other market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the United States

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States

- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the United States pharmaceuticals market by value in 2017?

- What will be the size of the United States pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the United States pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in the United States's pharmaceuticals market?

Table of Contents

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7 ...

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 15

Supplier power 17

New entrants 19

Threat of substitutes 21

Degree of rivalry 22

Leading Companies 24

AstraZeneca PLC 24

Johnson & Johnson 27

Merck & Co., Inc. 30

Pfizer Inc. 33

Macroeconomic Indicators 37

Country data 37

Methodology 39

Industry associations 40

Related MarketLine research 40

Appendix 41

About MarketLine 41

List of Tables

List of Tables

Table 1: United States pharmaceuticals market value: $ billion, 2013-17

Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2017

Table 3: United ...

List of Tables

Table 1: United States pharmaceuticals market value: $ billion, 2013-17

Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2017

Table 3: United States pharmaceuticals market share: % share, by value, 2017

Table 4: United States pharmaceuticals market value forecast: $ billion, 2017-22

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials ($)

Table 7: AstraZeneca PLC: key financial ratios

Table 8: Johnson & Johnson: key facts

Table 9: Johnson & Johnson: key financials ($)

Table 10: Johnson & Johnson: key financial ratios

Table 11: Merck & Co., Inc.: key facts

Table 12: Merck & Co., Inc.: key financials ($)

Table 13: Merck & Co., Inc.: key financial ratios

Table 14: Pfizer Inc.: key facts

Table 15: Pfizer Inc.: key financials ($)

Table 16: Pfizer Inc.: key financial ratios

Table 17: United States size of population (million), 2013-17

Table 18: United States gdp (constant 2005 prices, $ billion), 2013-17

Table 19: United States gdp (current prices, $ billion), 2013-17

Table 20: United States inflation, 2013-17

Table 21: United States consumer price index (absolute), 2013-17

Table 22: United States exchange rate, 2013-17

List of Figures

List of Figures

Figure 1: United States pharmaceuticals market value: $ billion, 2013-17

Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2017

Figure ...

List of Figures

Figure 1: United States pharmaceuticals market value: $ billion, 2013-17

Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: United States pharmaceuticals market share: % share, by value, 2017

Figure 4: United States pharmaceuticals market value forecast: $ billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in the United States, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in the United States, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in the United States, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2017

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Johnson & Johnson: revenues & profitability

Figure 14: Johnson & Johnson: assets & liabilities

Figure 15: Merck & Co., Inc.: revenues & profitability

Figure 16: Merck & Co., Inc.: assets & liabilities

Figure 17: Pfizer Inc.: revenues & profitability

Figure 18: Pfizer Inc.: assets & liabilities

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports